INSIGHTS ON DRUG DEVELOPMENT

• Collaboration An Untapped Fuel For Driving Biopharma R&D

  Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.

• Ask Us Anything: Matt Bio On Peptide Commercialization Trends

  Matt Bio, CSO of Cambrex and President of Snapdragon Chemistry, on the capacity bottleneck behind peptide shortages — and why moving from solid-phase to liquid-phase synthesis unlocks reactors already sitting idle around the world.

• The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly

  In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

• A Sensory Panel Study With The Focus On High-Intensity Sweeteners

  Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.

• Column Selection For RPLC-UV Impurity Analysis

  7/17/2025

  Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.

• Ask Us Anything: Erik Feldmann On Advancing Peptide Development

  7/24/2026

  Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.

• Spray Dried Biologics For Pulmonary Dosage Forms

  5/15/2026

  Spray drying creates stable inhalable biologic powders with controlled particle size, enabling effective lung delivery, improved stability, and scalable production for respiratory and systemic therapies.

• Data-Driven Strategies To De-Risk OSD Development

  6/17/2026

  Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

• Direct Amplification Of Cell Culture Samples

  6/15/2026

  Skip extraction and move straight to amplification with a streamlined qPCR workflow. Achieve comparable performance across multiple targets while reducing costs and saving time.